NCT04328844 2026-03-30A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic CancersiOncturaPhase 1 Active not recruiting210 enrolled
NCT02436707 2026-03-27Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell LymphomaCanadian Cancer Trials GroupPhase 2 Active not recruiting129 enrolled
NCT05502250 2026-03-06HOVON164HLStichting Hemato-Oncologie voor Volwassenen NederlandPhase 2 Active not recruiting75 enrolled